Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Methods in Molecular Biology (Clifton, N.J.)|June 12, 2020
Molecular Genetic Screening of CCM Patients: An OverviewElisabeth Tournier-LasserveThe Lancet. Neurology|July 10, 2003
The genetics of migraineAnne Ducros, Elisabeth Tournier-Lasserve, Marie-Germaine BousserDevelopmental Cell|February 17, 2009
The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implicationsElisabetta Dejana, Elisabeth Tournier-Lasserve, Brant M WeinsteinMedecine Sciences : M/S|January 11, 2007
[Role of P/Q calcium channel in familial hemiplegic migraine]Norbert Weiss, Elisabeth Tournier-Lasserve, Michel De WaardTrends in Molecular Medicine|July 22, 2020
Blocking Signalopathic Events to Treat Cerebral Cavernous MalformationsSalim Abdelilah-Seyfried, Elisabeth Tournier-Lasserve, W Brent DerryGene Expression Patterns : GEP|February 4, 2006
Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain developmentNathalie Petit, Anne Blécon, Christian Denier, et al.The Lancet. Neurology|February 17, 2007
Genetics of cavernous angiomasPierre Labauge, Christian Denier, Francoise Bergametti, et al.The Application of Clinical Genetics|March 4, 2015
Moyamoya disease and syndromes: from genetics to clinical managementStéphanie Guey, Elisabeth Tournier-Lasserve, Dominique Hervé, et al.Neurogenetics|April 19, 2013
CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletionsFlorence Riant, Michaelle Cecillon, Pascale Saugier-Veber, et al.Archives of Neurology|June 11, 2008
Large CACNA1A deletion in a family with episodic ataxia type 2Florence Riant, Reda Mourtada, Pascale Saugier-Veber, et al.Pageof 12